Progesterone and postpartum smoking relapse: A pilot double-blind placebo-controlled randomized trial

Nicotine and Tobacco Research

Volumn 18, Issue 11, 2016, Pages 2145-2153

  Allen, Sharon S ^a   Allen, Alicia M ^a   Lunos, Scott ^a   Tosun, Nicole ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROGESTERONE;

ADULT; ANXIETY DISORDER; ARTICLE; BREAST FEEDING; CLINIC VISIT ATTENDANCE; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG TOLERABILITY; EDUCATIONAL STATUS; ELECTRONIC MEDICAL RECORD; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT SAFETY; PILOT STUDY; POINT PREVALENCE; POSTPARTUM SMOKING RELAPSE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SMOKING; SMOKING CESSATION; SMOKING HABIT; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; BLOOD; DRUG THERAPY; ORAL DRUG ADMINISTRATION; POSTNATAL DEPRESSION; PREGNANCY; PREVENTION AND CONTROL; PROCEDURES; PSYCHOLOGY; PUERPERIUM; RECURRENT DISEASE; SECONDARY PREVENTION; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; DEPRESSION, POSTPARTUM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; PILOT PROJECTS; POSTPARTUM PERIOD; PREGNANCY; PROGESTERONE; RECURRENCE; SECONDARY PREVENTION; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84994530368     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntw156     Document Type: Article

References (63)

1. Tong VT, Jones JR, Dietz PM, D'Angelo D, Bombard JM. Trends in smoking before, during, and after pregnancy-Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000-2005. Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C.: 2002). 2009. www.cdc.gov/mmwr/preview/mmwrhtml/ss5804a1.htm. Accessed November 23, 2015.
2. Tong VT, Jones JR, Dietz PM, D'Angelo D, Bombard JM. Trends in smoking before, during, and after pregnancy-Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000-2005. MMWR Surveill Summ. 2009;58(4):1-29. www.ncbi.nlm.nih.gov/pubmed/19478726 Accessed December 3, 2015.
3. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General, Executive Summary. 2014. www.cdc.gov/tobacco/data_statistics/sgr/50thanniversary/index.htm. Assessed December 7, 2015.
4. Hoedjes M, Berks D, Vogel I, et al. Effect of postpartum lifestyle interventions on weight loss, smoking cessation, and prevention of smoking relapse: a systematic review. Obstet Gynecol Surv. 2010;65(10):631-652. doi:10.1097/OGX.0b013e3182077f64.
5. Jiménez-Muro A, Nerín I, Samper P, et al. A proactive smoking cessation intervention in postpartum women. Midwifery. 2013;29(3):240-245. doi:10.1016/j.midw.2012.01.003.
6. Tong VT, Dietz PM, England LJ. "Smoking cessation for pregnancy and beyond: a virtual clinic," an innovative web-based training for healthcare professionals. J Womens Health (Larchmt). 2012;21(10):1014-1017. doi:10.1089/jwh.2012.3871.
7. Herbec A, Brown J, Tombor I, Michie S, West R. Pilot randomized controlled trial of an internet-based smoking cessation intervention for pregnant smokers ('MumsQuit'). Drug Alcohol Depend. 2014;140:130-136. doi:10.1016/j.drugalcdep.2014.04.010.
8. Lopez AA, Skelly JM, Higgins ST. Financial incentives for smoking cessation among depression-prone pregnant and newly postpartum women: effects on smoking abstinence and depression ratings. Nicotine Tob Res. 2015;17(4):455-462. doi:10.1093/ntr/ntu193.
9. Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. Cochrane Database Syst Rev. 2015;5:CD004307. doi:10.1002/14651858. CD004307.pub5.
10. Ierfino D, Mantzari E, Hirst J, Jones T, Aveyard P, Marteau TM. Financial incentives for smoking cessation in pregnancy: a single-arm intervention study assessing cessation and gaming. Addiction. 2015;110(4):680-688. doi:10.1111/add.12817.
11. Einarson A, Riordan S. Smoking in pregnancy and lactation: a review of risks and cessation strategies. Eur J Clin Pharmacol. 2009;65(4):325-330. doi:10.1007/s00228-008-0609-0.
12. Hemsing N, Greaves L, O'Leary R, Chan K, Okoli C. Partner support for smoking cessation during pregnancy: a systematic review. Nicotine Tob Res. 2012;14(7):767-776. doi:10.1093/ntr/ntr278.
13. Agboola S, McNeill A, Coleman T, Leonardi Bee J. A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers. Addiction. 2010;105(8):1362-1380. doi:10.1111/j.1360-0443.2010.02996.x.
14. Anker JJ, Carroll ME. The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research. Neurosci Biobehav Rev. 2010;35(2):315-333. doi:10.1016/j.neubiorev.2010.04.003.
15. Lynch WJ, Sofuoglu M. Role of progesterone in nicotine addiction: evidence from initiation to relapse. Exp Clin Psychopharmacol. 2010;18(6):451-461. doi:10.1037/a0021265.
16. Allen SS, Bade T, Center B, Finstad D, Hatsukami D. Menstrual phase effects on smoking relapse. Addiction. 2008;103(5):809-821. doi:10.1111/j.1360-0443.2008.02146.x.
17. Allen AM, Allen SS, Lunos S, Pomerleau CS. Severity of withdrawal symptomatology in follicular versus luteal quitters: The combined effects of menstrual phase and withdrawal on smoking cessation outcome. Addict Behav. 2010;35(6):549-552. doi:10.1016/j.addbeh.2010.01.003.
18. Franklin TR, Ehrman R, Lynch KG, et al. Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt). 2008;17(2):287-292. doi:10.1089/jwh.2007.0423.
19. Mazure CM, Toll B, McKee SA, Wu R, O'Malley SS. Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion. Drug Alcohol Depend. 2011;114(1):68-72. doi:10.1016/j.drugalcdep.2010.07.024.
20. Wetherill RR, Franklin TR, Allen SS. Ovarian hormones, menstrual cycle phase, and smoking: a review with recommendations for future studies. Curr Addict Reports. 2016;3(1):1-8. doi:10.1007/s40429-016-0093-z.
21. Albrecht ED, Pepe GJ. Endocrinology of pregnancy. In: Bazer FW, ed. Endocrinology of Pregnancy. Totowa, NJ: Humana Press; 1998:319-351. doi:10.1007/978-1-4612-1804-3.
22. Strauss J, Barbieri R. Yen & Jaffe's Reproductive Endocrinology. 7th ed. Philadelphia, PA: Elsevier Saunders; 2014.
23. Perkins KA, Karelitz JL, Jao NC. Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nicotine Tob Res. 2013;15(5):978-982 doi:10.1093/ntr/nts205.
24. al'Absi M, Lovallo WR, McKey BS, Pincomb GA. Borderline hypertensives produce exaggerated adrenocortical responses to mental stress. Psychosom Med. 1994;56(3):245-250. www.ncbi.nlm.nih.gov/pubmed/8084971. Accessed March 25, 2016.
25. al'Absi M, Lovallo WR, McKey B, Sung BH, Whitsett TL, Wilson MF. Hypothalamic-pituitary-adrenocortical responses to psychological stress and caffeine in men at high and low risk for hypertension. Psychosom Med. 1998;60(4):521-527. www.ncbi.nlm.nih.gov/pubmed/9710300. Accessed March 25, 2016.
26. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150(6):782-786. www.ncbi.nlm.nih.gov/pubmed/3651732. Accessed March 16, 2015.
27. Rubertsson C, Börjesson K, Berglund A, Josefsson A, Sydsjö G. The Swedish validation of Edinburgh Postnatal Depression Scale (EPDS) during pregnancy. Nord J Psychiatry. 2011;65(6):414-418. doi:10.3109/080 39488.2011.590606.
28. Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav. 2007;32(5):912-923. doi:10.1016/j.addbeh.2006.06.028.
29. Neville MC, Morton J, Umemura S. Lactogenesis. The transition from pregnancy to lactation. Pediatr Clin North Am. 2001;48(1):35-52. www.ncbi.nlm.nih.gov/pubmed/11236732. Accessed December 7, 2015.
30. Neville MC, Morton J. Physiology and endocrine changes underlying human lactogenesis II. J Nutr. 2001;131(11):3005S-3008. http://jn.nutrition.org/content/131/11/3005S.full. Accessed December 7, 2015.
31. Entwistle F. The evidence and rationale for the UNICEF UK Baby Friendly Initiative standards. 2013:51. www.unicef.org.uk/BabyFriendly/Resources/Guidance-for-Health-Professionals/Writingpolicies-and-guidelines/guide-to-the-baby-friendly-initiative-standards/. Accessed December 7, 2015.
32. Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266-1277. doi:10.1176/appi.ajp.2011.10111704.
33. Brown RA, Burgess ES, Sales SD, Whiteley JA, Evans DM, Miller IW. Reliability and validity of a smoking timeline follow-back interview. Psychol Addict Behav. 1998;12(2):101-112. doi:10.1037/0893-164X.12.2.101.
34. Gariti PW, Alterman AI, Ehrman RN, Pettinati HM. Reliability and validity of the aggregate method of determining number of cigarettes smoked per day. Am J Addict. 1998;7(4):283-287. www.ncbi.nlm.nih.gov/pubmed/9809132 Accessed February 12, 2016.
35. Sofuoglu M, Babb DA, Hatsukami DK. Effects of progesterone treatment on smoked cocaine response in women. Pharmacol Biochem Behav. 2002;72(1-2):431-435. www.ncbi.nlm.nih.gov/pubmed/11900816. Accessed February 12, 2016.
36. McAuley JW, Kroboth FJ, Kroboth PD. Oral administration of micronized progesterone: a review and more experience. Pharmacotherapy. 1996;16(3):453-457. www.ncbi.nlm.nih.gov/pubmed/8726605. Accessed December 29, 2015.
37. Progesterone. PRD Health website. 2014. www.pdr.net. Accessed February 12, 2016.
38. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. doi:10.1016/j.jbi.2008.08.010.
39. Elisa DRGP. Progesterone ELISA kit. 2007;2007(908):1-10.
40. Murphy SE, Park S-SL, Thompson EF, et al. Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups. Carcinogenesis. 2014;35(11):2526-2533. doi:10. 1093/carcin/bgu191.
41. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004 Am J Epidemiol. 2009;169(2):236-248. doi:10.1093/aje/kwn301.
42. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003;5(1):13-25. www.ncbi.nlm.nih.gov/pubmed/12745503 Accessed December 4, 2015.
43. SAS v9.3. 2010. Cary, NC: SAS Institute Inc.; 2011.
44. Yonkers KA, Forray A, Nich C, et al. Progesterone reduces cocaine use in postpartum women with a cocaine use disorder: a randomized,doubleblind study. Lancet Psychiatry. 2014;1(5):360-367. doi:10.1016/S2215-0366(14)70333-5.
45. Oncken C, Gonzales D, Nides M, et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med. 2006;166(15):1571-1577. doi:10.1001/archinte.166.15.1571.
46. Jorenby DE. Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial. JAMA. 2006;296(1):56. doi:10.1001/jama.296.1.56.
47. Okuyemi KS, Thomas JL, Hall S, et al. Smoking cessation in homeless populations: a pilot clinical trial. Nicotine Tob Res. 2006;8(5):689-699. doi:10.1080/14622200600789841.
48. Napolitano MA, Lloyd-Richardson EE, Fava JL, Marcus BH. Targeting body image schema for smoking cessation among college females: rationale, program description, and pilot study results. Behav Modif. 2011;35(4):323-346. doi:10.1177/0145445511404840.
49. Bisaga A, Aharonovich E, Garawi F, et al. A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend. 2006;81(3):267-274. doi:10.1016/j.drugalcdep.2005.07.009.
50. López-Pelayo H, Batalla A, Balcells MM, Colom J, Gual A. Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments. Psychol Med. 2015;45(6):1121-1133. doi:10.1017/S0033291714002463.
51. Leischow SJ, Muramoto ML, Matthews E, Floden LL, Grana RA. Adolescent smoking cessation with bupropion: the role of adherence. Nicotine Tob Res. 2015;18(5):1-4. doi:10.1093/ntr/ntv179.
52. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustainedrelease bupropion and placebo for smoking cessation. N Engl J Med. 1997;337(17):1195-1202. doi:10.1056/NEJM199710233371703.
53. Koegelenberg CFN, Noor F, Bateman ED, et al. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. JAMA. 2014;312(2):155-161 doi:10.1001/jama.2014.7195.
54. Kendzor DE, Businelle MS, Costello TJ, et al. Breast feeding is associated with postpartum smoking abstinence among women who quit smoking due to pregnancy. Nicotine Tob Res. 2010;12(10):983-988. doi:10.1093/ntr/ntq132.
55. DiSantis KI, Collins BN, McCoy ACS. Associations among breastfeeding, smoking relapse, and prenatal factors in a brief postpartum smoking intervention. Acta Obstet Gynecol Scand. 2010;89(4):582-586. doi:10.3109/00016341003678435.
56. Harmer C, Memon A. Factors associated with smoking relapse in the postpartum period: an analysis of the child health surveillance system data in Southeast England. Nicotine Tob Res. 2013;15(5):904-909. doi:10.1093/ntr/nts221.
57. Sofuoglu M, Mouratidis M, Mooney M. Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology. 2011;36(1):123-132. doi:10.1016/j.psyneuen.2010.07.005.
58. Breastfeeding: Data & Statistics website. 2015. www.cdc.gov. Accessed February 12, 2016.
59. Husky MM, Mazure CM, Paliwal P, McKee SA. Gender differences in the comorbidity of smoking behavior and major depression. Drug Alcohol Depend. 2008;93(1-2):176-179. doi:10.1016/j.drugalcdep.2007.07.015.
60. Thombs BD, Benedetti A, Kloda LA, et al. Diagnostic accuracy of the Edinburgh Postnatal Depression Scale (EPDS) for detecting major depression in pregnant and postnatal women: protocol for a systematic review and individual patient data meta-analyses. BMJ Open. 2015;5(10):e009742. doi:10.1136/bmjopen-2015-009742.
61. Hitsman B, Papandonatos GD, McChargue DE, et al. Past major depression and smoking cessation outcome: a systematic review and meta-analysis update. Addiction. 2013;108(2):294-306. doi:10.1111/add.12009.
62. Zvolensky MJ, Bakhshaie J, Sheffer C, Perez A, Goodwin RD. Major depressive disorder and smoking relapse among adults in the United States: a 10-year, prospective investigation. Psychiatry Res. 2015;226(1):73-77. doi:10.1016/j.psychres.2014.11.064.
63. Allen AM, Prince CB, Dietz PM. Postpartum depressive symptoms and smoking relapse. Am J Prev Med. 2009;36(1):9-12. doi:10.1016/j.amepre.2008.09.020.